<DOC>
	<DOC>NCT00111488</DOC>
	<brief_summary>The purpose of the Randomized Study of Surgical Ablation with Microwave Energy for the Treatment of Atrial Fibrillation (RESOLVE-AF) trial is to determine the safety and effectiveness of the Guidant FLEXÂ® Microwave Surgical Ablation System in the treatment of permanent atrial fibrillation (AF).</brief_summary>
	<brief_title>Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patient age &gt;= 18 years Documented permanent AF (for at least three months) Scheduled for an open chest cardiac surgery for the primary indication of mitral valve repair or replacement Has been informed of the nature of the study, agrees to its provisions, and provided written informed consent, which was approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site Cerebral vascular accident (CVA, stroke) or transient ischemic attack (TIA) within the previous 6 months Myocardial infarction within the previous 6 weeks Documented history of pulmonary vein stenosis Previous ablation attempt for AF Previous thoracic procedures Left atrial size &gt; 7.0 cm Left ventricular ejection fraction &lt; 30% Presence of left atrial or left atrial appendage thrombi Esophageal fistula or other stricture, untreated esophagitis, varices, dysphagia or odynophagia contraindicating transesophageal echocardiography Known allergy or contraindication to warfarin therapy Known allergy or contraindication to antiarrhythmic (Classes IA, IC, III) therapy Other comorbidity with reduced life expectancy of less than 1 year or protocol noncompliance that would limit followup Geographically remote or unable to return for followup examinations Pregnant or planning to become pregnant during the study Enrolled in any concurrent study, without Guidant written approval, that may confound the results of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>atrial fibrillation</keyword>
</DOC>